🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated — grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≤24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months — use filters for patent-cliff planning.

Page 156 of 173

  1. US 6596544

    Functional assay of high-density lipoprotein

    Expires Mon Jul 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6593459

    Synthetic glycosulfopeptides and methods of synthesis thereof

    Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6593307

    Cyclic-ADP-ribose analogs

    Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6593306

    Methods for modulation and inhibition of telomerase

    Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6593308

    Targeted drug delivery with a hyaluronan ligand

    Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6593456

    Tumor necrosis factor receptor releasing enzyme

    Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6590140

    Metal-regulated transporters and uses therefor

    Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6589531

    Recombinant yellow fever virus and method of use thereof

    Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6589507

    Foaming antacid suspension tablets

    Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6589957

    Compounds and methods of use for treatment of neurogenic inflammation

    Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6585981

    Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae

    Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6586242

    TAO protein kinases and methods of use therefor

    Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6586460

    Heteroarotinoids containing urea or thiourea linker

    Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6586419

    Phototherapeutic inactivation of ocular viruses

    Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6582725

    Human PEA3 is a tumor suppressor for cancer cells

    Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6583271

    Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins

    Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6582950

    C3 binding polypeptide of Streptococcus agalactiae group b Streptococcus

    Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6579684

    Assay of YKL-40 as a marker for cancer

    Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6579893

    Use of troglitazone and related compounds for the treatment of cancer

    Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6579695

    Phosphopantetheinyl transferases and uses thereof

    Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6576219

    Method for enhancing outflow of aqueous humor in treatment of glaucoma

    Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6576463

    Hybrid vectors for gene therapy

    Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6576650

    Peripherally active anti-hyperalgesic opiates

    Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6576465

    Human bone accessory cells

    Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6576264

    Insoluble drug delivery

    Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6576440

    Methods and compositions for wound healing

    Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6573236

    Inhibiting MOG-antibody binding

    Expires Mon May 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6573044

    Methods of using chemical libraries to search for new kinase inhibitors

    Expires Mon May 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6573062

    Method for obtaining modulators of TNF receptor releasing enzyme

    Expires Mon May 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6573282

    Peripherally active anti-hyperalgesic opiates

    Expires Mon May 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6569431

    Recombinant antibody fragments as autoantibody antagonists

    Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6569889

    Amino ceramide-like compounds and therapeutic methods of use

    Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6569664

    Native TNF receptor releasing enzyme

    Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6569995

    Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells

    Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6569998

    Synthetic glycosulfopeptides and methods of synthesis thereof

    Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6569470

    Monoamine oxidase (MAO) inhibitors and uses thereof

    Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6566500

    Compositions and methods for modifying toxic effects of proteinaceous compounds

    Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6565889

    Bilayer structure which encapsulates multiple containment units and uses thereof

    Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6565827

    Radioimmunotherapy of lymphoma using anti-CD20 antibodies

    Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6566324

    Preventing airway mucus production by administration of EGF-R antagonists

    Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6566326

    Chemically modified hemoglobin for burn shock resuscitation

    Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6566342

    Gene therapy by secretory gland expression

    Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6566494

    Support material for solid phase organic synthesis

    Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6562988

    Methods and products relating to 16-HETE analogs

    Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6562819

    Compounds for inhibition of ceramide-mediated signal transduction

    Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6562801

    PpGpp and pppGpp as immunomodulatory agents

    Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6562606

    Methods and compositions for disrupting the epithelial barrier function

    Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6558668

    Methods for detection and treatment of neural cancers

    Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.